RT Journal Article
SR Electronic
T1 651 A phase 1, multicenter, open-label, dose-escalation, safety, pharmacodynamic, pharmacokinetic study of Q702 with a cohort expansion at the RP2D in patients with advanced solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A742
OP A742
DO 10.1136/jitc-2023-SITC2023.0651
VO 11
IS Suppl 1
A1 Mahalingam, Devalingam
A1 Alistar, Angela
A1 Mita, Alain
A1 Kim, Jeongjun
A1 Ahn, Hyunji
A1 Choi, Jinho
A1 Ryu, Seung-Hee
A1 Ahn, Jiye
A1 Choi, Bae Jung
A1 Kang, Hwankyu
A1 Yang, Yeong-In
A1 Lee, Seung-Joo
A1 Jeon, Borami
A1 Proniuk, Stefan
A1 Nam, Kiyean
A1 El-Khoueiry, Anthony
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A742.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.